“Adjuvant Topical Dorzolamide or Timolol With Intravitreal Bevacizumab for Diabetic Macular Edema: A Double-Blind Randomized Controlled Trial”. Journal of Current Biomedical Reports 5, no. 1 (March 30, 2024): 14–19. Accessed April 22, 2026. https://www.jcbior.homes.iot-dashnet.ir/index.php/JCBioR/article/view/279.